stocks index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart pwall street isn’t ready for a point tumble in the dow industrials phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart pwall street isn’t ready for a point tumble in the dow industrials phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart pwall street isn’t ready for a point tumble in the dow industrials phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  foamix pharmaceuticals ltd private company information  bloomberg july    pm et pharmaceuticals company overview of foamix pharmaceuticals ltd snapshot people company overview foamix pharmaceuticals ltd a clinicalstage specialty pharmaceutical company develops and commercializes foambased formulations primarily for the treatment of moderatetosevere acne moderatetosevere papulopustular rosacea and other skin conditions in the united states germany and france its lead product candidates include fmx a novel topical foam formulation of the antibiotic minocycline which has completed a doseranging phase ii clinical trial for the treatment of moderatetosevere acne and fmx that has completed a phase ii clinical trial for the treatment of impetigo caused by methicillinresistant staphylococcus aureus the company is also developing fmx a ver foamix pharmaceuticals ltd a clinicalstage specialty pharmaceutical company develops and commercializes foambased formulations primarily for the treatment of moderatetosevere acne moderatetosevere papulopustular rosacea and other skin conditions in the united states germany and france its lead product candidates include fmx a novel topical foam formulation of the antibiotic minocycline which has completed a doseranging phase ii clinical trial for the treatment of moderatetosevere acne and fmx that has completed a phase ii clinical trial for the treatment of impetigo caused by methicillinresistant staphylococcus aureus the company is also developing fmx a version of its minocycline foam fmx which is in phase ii clinical trial for the treatment of rosacea and fdx that has completed phase ii clinical trial for the treatment of chemotherapyinduced rash foamix pharmaceuticals ltd has development and license agreements with bayer healthcare ag sebela pharmaceuticals inc mylan nv and actavis laboratories the company was founded in  and is headquartered in rehovot israel detailed description  holzman streetweizmann science parkrehovot  israelfounded in  employees phone     wwwfoamixcoil key executives for foamix pharmaceuticals ltd mr david t domzalski ceo  president age  total annual compensation k dr dov tamarkin phd cofounder  director age  total annual compensation k mr meir eini cofounder  innovation advisor age  total annual compensation k mr ilan hadar mba cfo  country manager age  total annual compensation k mr alvin d howard vice president of regulatory affairs  foamix pharmaceuticals inc age  total annual compensation k compensation as of fiscal year  foamix pharmaceuticals ltd key developments foamix pharmaceuticals ltd announces management changes jun   foamix pharmaceuticals ltd announced that its board of directors has named david domzalski as chief executive officer of the company effective immediately mr domzalski currently serves as president of foamixs us subsidiary he succeeds dr dov tamarkin as ceo dr tamarkin will continue to be a member of the companys board of directors and will serve as chief scientific advisor to foamix the company also announced that mr meir eini will be stepping down from his current role of chief innovation officer and will continue to serve as an innovation advisor to foamix mr ilan hadar the current chief financial officer of foamix will assume the role of country manager in israel in addition to his role as chief financial officer dave domzalski joined foamix in  and has served for the past three years as president of foamix pharmaceuticals inc foamix pharmaceuticals ltd announces dosing of first patient in phase  rosacea clinical trials for fmx minocycline foam  jun   foamix pharmaceuticals ltd announced that the first patient has been dosed in its phase  program to evaluate the efficacy and safety of its topical minocycline foam  fmx the phase  program consists of two multicenter studies  each study will enroll approximately  patients with moderatetosevere papulopustular rosacea into a week doubleblind vehiclecontrolled phase  this will be followed by a month openlabel safety extension phase with the active  minocycline foam  both studies will be conducted at multiple sites throughout the united states  patients will be randomized on a  basis  minocycline foam vs vehicle and treated once daily for  weeks in the initial doubleblind portions of the studies the primary efficacy endpoints are  the proportion of patients achieving success at week  based on an investigators global assessment and  the mean change from baseline in inflammatory lesion counts in each treatment group at week   safety evaluation will include reported adverse events assessments of tolerability clinical laboratory tests and vital signs patients who complete the  weeks of treatment will have the option to continue in a longterm openlabel safety extension to evaluate the safety of intermittent use of fmx for up to an additional  months foamix expects to report topline results from the blinded phase of the clinical trials mid foamix pharmaceuticals ltd annual general meeting jul   jun   foamix pharmaceuticals ltd annual general meeting jul   at  israel standard time location  holzman st entrance b weizmann science park rehovot israel agenda to appoint kesselman  kesselman pwc israel as their independent registered public accounting firm for the year  and authorize the board to determine the compensation of the auditors to ratify the election of dr dalia megiddo as their director to approve the terms of compensation of dr stanley hirsch chairman of the board of directors for the year  and onward to approve the award of additional options and restricted share units to the companys nonexecutive directors and to approve an increase of the authorized share capital of the company by an additional ils  divided into  ordinary shares with a nominal value of ils  per share similar private companies by industry company name region abital pharma pipelines ltd middle eastafrica active px ltd middle eastafrica advanced inhalation technology ltd middle eastafrica angio b ltd middle eastafrica antaki center for herbal medicine ltd middle eastafrica recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact foamix pharmaceuticals ltd please visit wwwfoamixcoil company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft fomx stock price  foamix pharmaceuticals ltd stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated longdated treasury yields see weekly climb p updated sp  nasdaq finish lower after amazon disappointment dow closes at record p updated the highest paid athletes in the world in one chart p updated wall street isn’t ready for a point tumble in the dow industrials p updated how to raise your kids to be frugal but not too frugal p updated cities to move to if you want to work in tech — not including san francisco p updated what donald trump’s battle of wills with jeff sessions teaches you about a difficult boss p trump russia and sanctions what we know p updated one way you’re paying creditcard fees even if you don’t have a card p updated this is the worst mistake people make at work to be replaced home investing quotes stocks united states fomx overview compare quotes stock screener earnings calendar sectors nasdaq fomx us nasdaq join td ameritrade find a broker foamix pharmaceuticals ltd watchlist createfomxalert after hours last updated jul    pm edt delayed quote     after hours volume  close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones biotech etf gets a lift from raptor deal foamix drug trial sep   at  am et by ryan vlastelica three top picks in smaller pharma alkermes alder biopharmaceuticals and aimmune are favorites and each has important catalysts coming up may   at  am et on barrons online recent news other news press releases new chief at foamix new chief at foamix jun   at  pm et on seeking alpha great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc  great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc therapeutics inc sells enanta pharmaceuticals inc merrimack pharmaceuticals inc colucid pharmaceuticals inc jun   at  pm et on gurufocuscom foamix commences latestage study of rosacea candidate fmx foamix commences latestage study of rosacea candidate fmx jun   at  am et on seeking alpha foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript may   at  am et on seeking alpha commentary on great point partners positions part  commentary on great point partners positions part  may   at  am et on seeking alpha day two of advance for foamix pharma on acne drug results day two of advance for foamix pharma on acne drug results may   at  pm et on seeking alpha three top picks in smaller pharma alkermes alder biopharmaceuticals and aimmune are favorites and each has important catalysts coming up may   at  am et on barrons midcap biopharma stocks pick up in the first quarter apr   at  pm et on seeking alpha foamix setback  yes thesis killer  no mar   at  pm et on seeking alpha allergan acne candidate meets endpoints in phase iii studies mar   at  am et on zackscom foamix pharmas fmx shows mixed results in two latestage acne studies shares plummet  premarket mar   at  am et on seeking alpha highpotential pipeline and sufficient cash make foamix pharmaceuticals a solid buy for  mar   at  pm et on seeking alpha foamix pharmaceuticals fomx th annual roth conference  mar   at  pm et on seeking alpha foamix pharmaceuticals fomx presents at cowen and company th annual health care conference mar   at  pm et on seeking alpha biotech forum daily digest upward resistance levels continue to hold spotlight on foamix pharmaceuticals mar   at  am et on seeking alpha foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript feb   at  pm et on seeking alpha premarket analyst action  healthcare feb   at  am et on seeking alpha foamix completes enrolment in phase iii acne drug studies nov   at  am et on zackscom foamix pharma completes enrollment in latestage studies of fmx nov   at  am et on seeking alpha  pharmaceuticals stocks to buy now nov   at  am et on investorplacecom foamix pharmaceuticals second quarter financial results conference call  webcast scheduled for august  foamix pharmaceuticals second quarter financial results conference call  webcast scheduled for august  jul   at  am et on globenewswire foamix pharmaceuticals appoints david domzalski as chief executive officer foamix pharmaceuticals appoints david domzalski as chief executive officer jun   at  am et on pr newswire  prf foamix pharmaceuticals to present at the  bio international convention foamix pharmaceuticals to present at the  bio international convention jun   at  am et on pr newswire  prf foamix announces dosing of first patient in phase  rosacea clinical trials for fmx minocycline foam  foamix announces dosing of first patient in phase  rosacea clinical trials for fmx minocycline foam  jun   at  am et on pr newswire  prf foamix pharmaceuticals to present at the jefferies  global healthcare conference foamix pharmaceuticals to present at the jefferies  global healthcare conference jun   at  am et on pr newswire  prf investor network foamix pharmaceuticals ltd to host earnings call investor network foamix pharmaceuticals ltd to host earnings call may   at  am et on accesswire foamix reports first quarter  financial results and provides business update foamix reports first quarter  financial results and provides business update may   at  pm et on pr newswire  prf foamix pharmaceuticals to present at the nd annual deutsche bank health care conference apr   at  am et on pr newswire  prf foamix pharmaceuticals first quarter financial results conference call  webcast scheduled for tuesday may  apr   at  am et on pr newswire  prf foamix reports topline results from phase  trials for fmx in patients with acne mar   at  am et on pr newswire  prf foamix pharmaceuticals to present at the barclays capital global healthcare conference mar   at  am et on pr newswire  prf foamix pharmaceuticals to present at the roth capital partners th annual growth conference mar   at  am et on pr newswire  prf foamix pharmaceuticals to present at the cowen  company th annual healthcare conference feb   at  am et on pr newswire  prf foamix pharmaceuticals to participate in a panel discussion at the dermatology innovation forum feb   at  am et on pr newswire  prf foamix reports year end  financial results and provides business update feb   at  am et on pr newswire  prf foamix pharmaceuticals to release fiscal year  financial results and host conference call  webcast on wednesday february  feb   at  pm et on pr newswire  prf foamix pharmaceuticals to present at the  bio ceo  investor conference feb   at  am et on pr newswire  prf blog coverage egalet announced positive results from human abuse potential study of egalet dec   at  am et on accesswire foamix to host key opinion leader luncheon for investors focused on dermatology with a focus on acne and rosacea nov   at  am et on pr newswire  prf foamix announces completion of patient enrollment in phase  acne trials for minocycline foam fmx nov   at  am et on pr newswire  prf foamix pharmaceuticals ltd foamix pharmaceuticals ltd engages in the development and commercialization of proprietary minocycline foam for the treatment of acne impetigo and other skin conditions its product portfolios include minocycline foam minocycline gel mometasone foam calcipotriene foam triamcinolone acetonide foam betamethasone valerate foam and betamethasone dipropionate the company was founded by dov tamarkin and meir eini on january   and is headquartered in rehovot israel see full profile analyst ratings sell under hold over buy number of ratings  full ratings biopharmx cfo talks clinical pipeline ahead of big q catalyst mar   at  pm et on benzingacom benzingas top initiations oct   at  am et on benzingacom barclays initiates foamix pharmaceuticals at overweight oct   at  am et on benzingacom competitors name chg  market cap achaogen inc  m contravir pharmaceuticals inc  m juniper pharmaceuticals inc  m zogenix inc  m competitor data provided by partner content trending tickers powered by dvax  mo  ssti  fl  aks  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience fomx stock price  foamix pharmaceuticals ltd stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated longdated treasury yields see weekly climb p updated sp  nasdaq finish lower after amazon disappointment dow closes at record p updated the highest paid athletes in the world in one chart p updated wall street isn’t ready for a point tumble in the dow industrials p updated how to raise your kids to be frugal but not too frugal p updated cities to move to if you want to work in tech — not including san francisco p updated what donald trump’s battle of wills with jeff sessions teaches you about a difficult boss p trump russia and sanctions what we know p updated one way you’re paying creditcard fees even if you don’t have a card p updated this is the worst mistake people make at work to be replaced home investing quotes stocks united states fomx overview compare quotes stock screener earnings calendar sectors nasdaq fomx us nasdaq join td ameritrade find a broker foamix pharmaceuticals ltd watchlist createfomxalert after hours last updated jul    pm edt delayed quote     after hours volume  close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones biotech etf gets a lift from raptor deal foamix drug trial sep   at  am et by ryan vlastelica three top picks in smaller pharma alkermes alder biopharmaceuticals and aimmune are favorites and each has important catalysts coming up may   at  am et on barrons online recent news other news press releases new chief at foamix new chief at foamix jun   at  pm et on seeking alpha great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc  great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc therapeutics inc sells enanta pharmaceuticals inc merrimack pharmaceuticals inc colucid pharmaceuticals inc jun   at  pm et on gurufocuscom foamix commences latestage study of rosacea candidate fmx foamix commences latestage study of rosacea candidate fmx jun   at  am et on seeking alpha foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript may   at  am et on seeking alpha commentary on great point partners positions part  commentary on great point partners positions part  may   at  am et on seeking alpha day two of advance for foamix pharma on acne drug results day two of advance for foamix pharma on acne drug results may   at  pm et on seeking alpha three top picks in smaller pharma alkermes alder biopharmaceuticals and aimmune are favorites and each has important catalysts coming up may   at  am et on barrons midcap biopharma stocks pick up in the first quarter apr   at  pm et on seeking alpha foamix setback  yes thesis killer  no mar   at  pm et on seeking alpha allergan acne candidate meets endpoints in phase iii studies mar   at  am et on zackscom foamix pharmas fmx shows mixed results in two latestage acne studies shares plummet  premarket mar   at  am et on seeking alpha highpotential pipeline and sufficient cash make foamix pharmaceuticals a solid buy for  mar   at  pm et on seeking alpha foamix pharmaceuticals fomx th annual roth conference  mar   at  pm et on seeking alpha foamix pharmaceuticals fomx presents at cowen and company th annual health care conference mar   at  pm et on seeking alpha biotech forum daily digest upward resistance levels continue to hold spotlight on foamix pharmaceuticals mar   at  am et on seeking alpha foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript feb   at  pm et on seeking alpha premarket analyst action  healthcare feb   at  am et on seeking alpha foamix completes enrolment in phase iii acne drug studies nov   at  am et on zackscom foamix pharma completes enrollment in latestage studies of fmx nov   at  am et on seeking alpha  pharmaceuticals stocks to buy now nov   at  am et on investorplacecom foamix pharmaceuticals second quarter financial results conference call  webcast scheduled for august  foamix pharmaceuticals second quarter financial results conference call  webcast scheduled for august  jul   at  am et on globenewswire foamix pharmaceuticals appoints david domzalski as chief executive officer foamix pharmaceuticals appoints david domzalski as chief executive officer jun   at  am et on pr newswire  prf foamix pharmaceuticals to present at the  bio international convention foamix pharmaceuticals to present at the  bio international convention jun   at  am et on pr newswire  prf foamix announces dosing of first patient in phase  rosacea clinical trials for fmx minocycline foam  foamix announces dosing of first patient in phase  rosacea clinical trials for fmx minocycline foam  jun   at  am et on pr newswire  prf foamix pharmaceuticals to present at the jefferies  global healthcare conference foamix pharmaceuticals to present at the jefferies  global healthcare conference jun   at  am et on pr newswire  prf investor network foamix pharmaceuticals ltd to host earnings call investor network foamix pharmaceuticals ltd to host earnings call may   at  am et on accesswire foamix reports first quarter  financial results and provides business update foamix reports first quarter  financial results and provides business update may   at  pm et on pr newswire  prf foamix pharmaceuticals to present at the nd annual deutsche bank health care conference apr   at  am et on pr newswire  prf foamix pharmaceuticals first quarter financial results conference call  webcast scheduled for tuesday may  apr   at  am et on pr newswire  prf foamix reports topline results from phase  trials for fmx in patients with acne mar   at  am et on pr newswire  prf foamix pharmaceuticals to present at the barclays capital global healthcare conference mar   at  am et on pr newswire  prf foamix pharmaceuticals to present at the roth capital partners th annual growth conference mar   at  am et on pr newswire  prf foamix pharmaceuticals to present at the cowen  company th annual healthcare conference feb   at  am et on pr newswire  prf foamix pharmaceuticals to participate in a panel discussion at the dermatology innovation forum feb   at  am et on pr newswire  prf foamix reports year end  financial results and provides business update feb   at  am et on pr newswire  prf foamix pharmaceuticals to release fiscal year  financial results and host conference call  webcast on wednesday february  feb   at  pm et on pr newswire  prf foamix pharmaceuticals to present at the  bio ceo  investor conference feb   at  am et on pr newswire  prf blog coverage egalet announced positive results from human abuse potential study of egalet dec   at  am et on accesswire foamix to host key opinion leader luncheon for investors focused on dermatology with a focus on acne and rosacea nov   at  am et on pr newswire  prf foamix announces completion of patient enrollment in phase  acne trials for minocycline foam fmx nov   at  am et on pr newswire  prf foamix pharmaceuticals ltd foamix pharmaceuticals ltd engages in the development and commercialization of proprietary minocycline foam for the treatment of acne impetigo and other skin conditions its product portfolios include minocycline foam minocycline gel mometasone foam calcipotriene foam triamcinolone acetonide foam betamethasone valerate foam and betamethasone dipropionate the company was founded by dov tamarkin and meir eini on january   and is headquartered in rehovot israel see full profile analyst ratings sell under hold over buy number of ratings  full ratings biopharmx cfo talks clinical pipeline ahead of big q catalyst mar   at  pm et on benzingacom benzingas top initiations oct   at  am et on benzingacom barclays initiates foamix pharmaceuticals at overweight oct   at  am et on benzingacom competitors name chg  market cap achaogen inc  m contravir pharmaceuticals inc  m juniper pharmaceuticals inc  m zogenix inc  m competitor data provided by partner content trending tickers powered by dvax  mo  ssti  fl  aks  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience company profile foamix  innovative versatile topical foams with ip protection home about technology lead products partnering intellectual property investors contact us search company profile foamix is a specialty pharmaceutical company focused on the development and commercialization of proprietary innovative and differentiated topical drugs for dermatological therapy our clinical stage product candidates include fmx our novel minocycline foam for the treatment of moderatetosevere acne fmx for the treatment of impetigo fmx  for the treatment of rosacea and fdx our doxycycline foam for the management of acnelike rash induced by egfri anticancer drugs   in addition the company has development and license agreements relating to our technology with various pharmaceutical companies including bayer healthcare merz allergan and prestium     about company profile advisors management board of directors technology lead products partnering intellectual property investors contact us  all rights reserved to foamix fomx  stock quote for foamix pharmaceuticals ltd  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices foamix pharmaceuticals ltd nasdaq fomx us markets closed adchoices  ▼   after hours     july    pm edt delayed  minutes nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news foamix pharmaceuticals second quarter financial results conference call  webcast scheduled for august  nasdaq  days ago company overview of foamix pharmaceuticals inc bloomberg  days ago company overview of foamix pharmaceuticals ltd bloomberg  foamix pharmaceuticals ltd  product pipeline review   marketresearchstorecom  days ago sarepta therapeutics inc srpt receives  consensus pt from analysts bulhufas  foamix pharmaceuticals nasdaqfomx receiving somewhat favorable news coverage accern reports themarketsdailycom  foamix pharmaceuticals fomx stock fomx stock marketsinsidercom  analyst activity – credit suisse group reiterates buy on foamix pharmaceuticals nasdaqfomx marketexclusivecom  foamix pharmaceuticals ltd nasdaqfomx given buy rating at credit suisse group themarketsdailycom  foamix pharmaceuticals ltd nasdaqfomx given buy rating at credit suisse group breeze  foamix pharmaceuticals ltd  product pipeline review   reportsnreportscom  sarepta therapeutics inc nasdaqsrpt to release quarterly earnings on wednesday hoyentvcom  foamix pharmaceuticals ltd fomx receives an update from brokers desotoedgecom  eps for alder biopharmaceuticals inc aldr expected at  eleganthomesinlacom  foamix pharmaceuticals ltd nasdaqfomx appoints david domzalski as chief executive officer journaltranscriptcom  foamix pharmaceuticals ltd  product pipeline review   acutemarketreportscom  foamix pharmaceuticals ltd nasdaqfomx announced the appointment of ceo benchmarkmonitorcom  foamix pharmaceuticals names david domzalski as ceo poandpocom  adchoices adchoices adchoices markets dow dow ▲    last updated time   pm edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support fomx key statistics  foamix pharmaceuticals ltd financial ratios  marketwatch bulletin investor alert new york markets after hours market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close foamix pharmaceuticals ltd nasdaq fomx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus foamix pharmaceuticals ltd after hours  quotes are delayed by  min jul    pm fomx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite todays close     change   day low day high    week low  week high   company description foamix pharmaceuticals ltd engages in the development and commercialization of proprietary minocycline foam for the treatment of acne impetigo and other skin conditions its product portfolios include minocycline foam minocycline gel mometasone foam calcipotriene foam triamcinolone acetonide  foamix pharmaceuticals ltd engages in the development and commercialization of proprietary minocycline foam for the treatment of acne impetigo and other skin conditions its product portfolios include minocycline foam minocycline gel mometasone foam calcipotriene foam triamcinolone acetonide foam betamethasone valerate foam and betamethasone dipropionate the company was founded by dov tamarkin and meir eini on january   and is headquartered in rehovot israel valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  officers and executives name age officer since title dr stanley hirsch   chairman mr david domzalski   chief executive officer mr ilan hadar   chief financial officer dr herman ellman   vice presidentclinical development mr yohan hazot   chief technology officer insider actions – purchase – sale  – number of transactions  newslatestcompanyusfomx marketwatch news on fomx biotech etf gets a lift from raptor deal foamix drug trial  am sept    ryan vlastelica newsnonmarketwatchcompanyusfomx other news on fomx new chief at foamix  pm june    seeking alpha great point partners llc buys concert pharmaceuticals inc rigel pharmaceuticals inc ptc   pm june    gurufocuscom foamix commences latestage study of rosacea candidate fmx  am june    seeking alpha foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript  am may    seeking alpha commentary on great point partners positions part   am may    seeking alpha day two of advance for foamix pharma on acne drug results  pm may    seeking alpha three top picks in smaller pharma  am may    barronscom midcap biopharma stocks pick up in the first quarter  pm april    seeking alpha foamix setback  yes thesis killer  no  pm march    seeking alpha allergan acne candidate meets endpoints in phase iii studies  am march    zackscom foamix pharmas fmx shows mixed results in two latestage acne studies shares plummet  premarket  am march    seeking alpha highpotential pipeline and sufficient cash make foamix pharmaceuticals a solid buy for   pm march    seeking alpha foamix pharmaceuticals fomx th annual roth conference   pm march    seeking alpha foamix pharmaceuticals fomx presents at cowen and company th annual health care conference  pm march    seeking alpha biotech forum daily digest upward resistance levels continue to hold spotlight on foamix pharmaceuticals  pm march    seeking alpha foamix pharmaceuticals fomx ceo dov tamarkin on q  results  earnings call transcript  pm feb    seeking alpha premarket analyst action  healthcare  am feb    seeking alpha foamix completes enrolment in phase iii acne drug studies  am nov    zackscom foamix pharma completes enrollment in latestage studies of fmx  am nov    seeking alpha  pharmaceuticals stocks to buy now  am nov    investorplacecom loading more headlines at a glance foamix pharmaceuticals ltd  holzman street weizmannscience park rehovot hm  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for fomx newspressreleasecompanyusfomx press releases on fomx foamix pharmaceuticals second quarter financial results conference call  webcast scheduled for august   am july    globenewswire foamix pharmaceuticals appoints david domzalski as chief executive officer  am june    pr newswire  prf foamix pharmaceuticals to present at the  bio international convention  am june    pr newswire  prf foamix announces dosing of first patient in phase  rosacea clinical trials for fmx minocycline foam   am june    pr newswire  prf foamix pharmaceuticals to present at the jefferies  global healthcare conference  am june    pr newswire  prf investor network foamix pharmaceuticals ltd to host earnings call  am may    accesswire foamix reports first quarter  financial results and provides business update  pm may    pr newswire  prf foamix pharmaceuticals to present at the nd annual deutsche bank health care conference  am april    pr newswire  prf foamix pharmaceuticals first quarter financial results conference call  webcast scheduled for tuesday may   am april    pr newswire  prf foamix reports topline results from phase  trials for fmx in patients with acne  am march    pr newswire  prf foamix pharmaceuticals to present at the barclays capital global healthcare conference  am march    pr newswire  prf foamix pharmaceuticals to present at the roth capital partners th annual growth conference  am march    pr newswire  prf foamix pharmaceuticals to present at the cowen  company th annual healthcare conference  am feb    pr newswire  prf foamix pharmaceuticals to participate in a panel discussion at the dermatology innovation forum  am feb    pr newswire  prf foamix reports year end  financial results and provides business update  am feb    pr newswire  prf foamix pharmaceuticals to release fiscal year  financial results and host conference call  webcast on wednesday february   pm feb    pr newswire  prf foamix pharmaceuticals to present at the  bio ceo  investor conference  am feb    pr newswire  prf blog coverage egalet announced positive results from human abuse potential study of egalet  am dec    accesswire foamix to host key opinion leader luncheon for investors focused on dermatology with a focus on acne and rosacea  am nov    pr newswire  prf foamix announces completion of patient enrollment in phase  acne trials for minocycline foam fmx  am nov    pr newswire  prf loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart pwall street isn’t ready for a point tumble in the dow industrials phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  foamix pharmaceuticals foamix pharmaceuticals ltd  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports foamix pharmaceuticals ltd  product pipeline review   foamix pharmaceuticals ltd  product pipeline review   wgr  september  global  pages global markets direct description table of content sample report enquiry before buy related reports foamix pharmaceuticals ltd  product pipeline review   summary global markets direct’s ‘foamix pharmaceuticals ltd  product pipeline review  ’ provides an overview of the foamix pharmaceuticals ltd’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of foamix pharmaceuticals ltd’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of foamix pharmaceuticals ltd including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of foamix pharmaceuticals ltd’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the foamix pharmaceuticals ltd’s pipeline products reasons to buy  evaluate foamix pharmaceuticals ltd’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of foamix pharmaceuticals ltd in its therapy areas of focus  identify new drug targets and therapeutic classes in the foamix pharmaceuticals ltd’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of foamix pharmaceuticals ltd and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of foamix pharmaceuticals ltd  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of foamix pharmaceuticals ltd and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  foamix pharmaceuticals ltd snapshot  foamix pharmaceuticals ltd overview  key information  key facts  foamix pharmaceuticals ltd  research and development overview  key therapeutic areas  foamix pharmaceuticals ltd  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  partnered products  partnered productscombination treatment modalities  foamix pharmaceuticals ltd  pipeline products glance  foamix pharmaceuticals ltd  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  foamix pharmaceuticals ltd  early stage pipeline products  preclinical productscombination treatment modalities  foamix pharmaceuticals ltd  drug profiles  doxycycline  product description  mechanism of action  rd progress  fmx  product description  mechanism of action  rd progress  minocycline  product description  mechanism of action  rd progress  mometasone furoate  product description  mechanism of action  rd progress  acyclovir  product description  mechanism of action  rd progress  benzoyl peroxide  product description  mechanism of action  rd progress  ciclopirox olamine  product description  mechanism of action  rd progress  estradiol hemihydrate  product description  mechanism of action  rd progress  imiquimod  product description  mechanism of action  rd progress  foamix pharmaceuticals ltd  pipeline analysis  foamix pharmaceuticals ltd  pipeline products by target  foamix pharmaceuticals ltd  pipeline products by route of administration  foamix pharmaceuticals ltd  pipeline products by molecule type  foamix pharmaceuticals ltd  pipeline products by mechanism of action  foamix pharmaceuticals ltd  recent pipeline updates  foamix pharmaceuticals ltd  dormant projects  foamix pharmaceuticals ltd  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables foamix pharmaceuticals ltd key information  foamix pharmaceuticals ltd key facts  foamix pharmaceuticals ltd  pipeline by indication   foamix pharmaceuticals ltd  pipeline by stage of development   foamix pharmaceuticals ltd  monotherapy products in pipeline   foamix pharmaceuticals ltd  partnered products in pipeline   foamix pharmaceuticals ltd  partnered products combination treatment modalities   foamix pharmaceuticals ltd  phase ii   foamix pharmaceuticals ltd  phase i   foamix pharmaceuticals ltd  preclinical   foamix pharmaceuticals ltd  pipeline by target   foamix pharmaceuticals ltd  pipeline by route of administration   foamix pharmaceuticals ltd  pipeline by molecule type   foamix pharmaceuticals ltd  pipeline products by mechanism of action   foamix pharmaceuticals ltd  recent pipeline updates   foamix pharmaceuticals ltd  dormant developmental projects  foamix pharmaceuticals ltd subsidiaries  list of figures foamix pharmaceuticals ltd  pipeline by top  indication   foamix pharmaceuticals ltd  pipeline by stage of development   foamix pharmaceuticals ltd  monotherapy products in pipeline   foamix pharmaceuticals ltd  pipeline by top  target   foamix pharmaceuticals ltd  pipeline by top  route of administration   foamix pharmaceuticals ltd  pipeline by top  molecule type   foamix pharmaceuticals ltd  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send contact us foamix  innovative versatile topical foams with ip protection home about technology lead products partnering intellectual property investors contact us search contact us foamix pharmaceuticals ltd  holzman street weizmannscience park rehovot  israel   tel    bdfoamixpharmacom foamix pharmaceuticals inc  us highway  suite  bridgewater new jersey  tel    irfoamixpharmacom mail address po box  ness ziona  israel for more information fill out the form and we will contact you full name company country united states united kingdom canada afghanistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas the bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon cape verde cayman islands central african republic chad chile china christmas island cocos islands colombia comoros congo congo democractic republic of the cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands faroe islands fiji islands finland france french guiana french polynesia french southern territories gabon gambia the georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong sar hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati korea korea north kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau sar macedonia former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands antilles netherlands the new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn island poland portugal puerto rico qatar reunion romania russia rwanda saint helena saint kitts and nevis saint lucia saint pierre and miquelon saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa south georgia and the south sandwich islands spain sri lanka sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united states minor outlying islands uruguay uzbekistan vanuatu vatican city state venezuela vietnam virgin islands virgin islands wallis and futuna islands yemen yugoslavia zambia zimbabwe email phone message mandatory filed about technology lead products partnering intellectual property investors contact us  all rights reserved to foamix fmx for impetigo foamix  innovative versatile topical foams with ip protection home about technology lead products partnering intellectual property investors contact us search fmx for impetigo impetigo is a highly contagious bacterial skin infection that primarily affects young children it is typically caused by staphylococcus aureus including mrsa and results in red sores and lesions on the face neck arms and legs mrsa infections occur in hospitals and healthcare facilities most commonly in pediatric wards in the early s mrsa accounted for only  of all staphylococcus aureus hospitalacquired infections in  it accounted for as much as  of these infections warranting the need for a better treatment topical antibiotic therapy is considered the treatment of choice for individuals with localized impetigo while systemic antibiotics are used for more widespread disease  topical mupirocin bactroban® is the most commonly used product to treat impetigo with dosing  three times daily for  to  days    foamix is developing fmx a  minocycline foam product candidate for the treatment of impetigo including cases of impetigo caused by mrsa  we conducted a sevenday randomized doubleblind phase ii clinical trial of  pediatric patients ages two to fifteen with at least two impetigo lesions eleven patients had confirmed mrsa infection patients receiving fmx twice daily experienced an  success rate in only three days and a  success rate in  days moreover all mrsainfected patients were free of the bacteria after seven days of treatment   fmx was well tolerated with none of the trial participants experiencing any drugrelated side effects additionally by treating the infection in as little as three days fmx may effectively limit the transfer of infection from one child to the other    the company plans to initiate phase iii clinical trials with fmx pending fda discussions    our lead products fmx fmx and fdx are covered by an issued us patent which is expected to remain in effect until    about technology lead products fmx for moderatetosevere acne fmx for impetigo fmx for rosacea fdx for chemotherapyinduced rash partnering intellectual property investors contact us  all rights reserved to foamix fmx for rosacea foamix  innovative versatile topical foams with ip protection home about technology lead products partnering intellectual property investors contact us search fmx for rosacea rosacea is a chronic skin disorder that is characterized by facial redness and inflammatory lesions afflicting an estimated  million people in the us alone there are several drugs currently prescribed for treating rosacea the most commonly used topical drugs are azelaic acid and metronidazole  oral antibiotics such as doxycycline and minocycline are also routinely prescribed  rosacea lesions and inflammatory acne lesions are dermatologically similar in many ways  based on our clinical data of fmx for moderatetosevere acne we intend to conduct initial clinical trials in the belief that fmx will be a safe and effective treatment for rosacea    phase ii clinical trial with fmx for rosacea is under way   about technology lead products fmx for moderatetosevere acne fmx for impetigo fmx for rosacea fdx for chemotherapyinduced rash partnering intellectual property investors contact us  all rights reserved to foamix foamix  home page foamix  innovative versatile topical foams with ip protection home about technology lead products partnering intellectual property investors contact us search lead products fmx for moderatetosevere acne fmx for impetigo fmx for rosacea fdx for chemotherapyinduced rash about foamix foamix is a specialty pharmaceutical company focused on the development and commercialization of proprietary innovative and differentiated topical drugs for dermatological therapy   our clinical stage product candidates include fmx our novel minocycline foam for the treatment of moderatetosevere acnefmx  for the treatment of rosacea  fmx for the treatment of impetigo and fdx our doxycycline foam for the management of acnelike rash induced by egfri anticancer drugs   minocycline foam we are developing a topical formulation of minocycline utilizing our proprietary foam technology platform our development program consists of three potential indications that we are pursuing moderatetosevere acne impetigo and rosacea     our phase ii results of minocycline foam  applied oncedaily for the treatment of moderatetosevere acne showed greater than a  reduction in inflammatory acne lesions we intend to commence phase iii trials for minocycline foam  in the united states in    recent news jun  foamix pharmaceuticals appoints david domzalski as chief executive officer read more jun  foamix pharmaceuticals to present at the  bio international conventionread more jun  foamix announces dosing of first patient in phase  rosacea clinical trials for fmx minocycline foam  read more  all rights reserved to foamix foamix pharmaceuticals to present at the jefferies  global healthcare conference  the business journals menu select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita limited time offer subscribe now search × close sign in sign in your account your account welcome your account sign in existing users create your free account dont have an account your account subscriptions newsletters custom notifications my custom site manage site users sign out sign in sign in your account search home industries  topics all industries  topics banking  financial services career  workplace commercial real estate education energy food  lifestyle government  regulations health care manufacturing media  marketing philanthropy  nonprofits professional services residential real estate retailing sports business technology transportation travel  tourism sponsored content cre now we value your business office environments small business marketing know your neighborhood news news latest news business pulse press releases lists  awards lists all lists build your own lists people  companies companies top private companies find businesses for sale search for company news people people on the move contact top executives executive profiles search for people in the news events events business event calendar nominations more… jobs find or post a job store subscriptions reprints  more how to grow your business advance your career thought leadership trends tips and insights from our partners subscribers manage your account about  contact about the business journals advertise help  faqs call center directory apps  syndication newsletters acbj publications bizwomen upstart hemmings sports business journal inside lacrosse bostinno dcinno chicagoinno austininno select a city national albany albuquerque atlanta austin baltimore birmingham boston buffalo charlotte chicago cincinnati columbus dallas dayton denver greensborowinstonsalem honolulu houston jacksonville kansas city los angeles louisville memphis miamifort lauderdale milwaukee minneapolisst paul nashville new york orlando philadelphia phoenix pittsburgh portland raleighdurham sacramento san antonio san francisco seattle silicon valley st louis tampa bay washington dc wichita follow us twitter linkedin facebook google  press releases foamix pharmaceuticals to present at the jefferies  global healthcare conference jun   am edt rehovot israel and bridgewater new jersey june   prnewswire  foamix pharmaceuticals ltd nasdaq fomx foamix a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology announced today that david domzalski president will present a corporate overview and business update at the jefferies  global healthcare conference being held on june   at the grand hyatt in new york city foamix pharmaceuticals presentation details date               tuesday june   time                pm eastern time location         the grand hyatt in new york city ny usa webcast        httpwswcomwebcastjefffomx           about foamix pharmaceuticals ltd foamix is a specialty pharmaceutical company focused on the development and commercialization of proprietary innovative and differentiated topical drugs for dermatological therapy our clinical stage product candidates include fmx our novel minocycline foam for the treatment of moderatetosevere acne fmx for the treatment of moderatetosevere rosacea fmx for the treatment of impetigo and fdx our doxycycline foam for the management of acnelike rash induced by egfri anticancer drugs in addition we have development and license agreements relating to our technology with various pharmaceutical companies including bayer healthcare and others for more information please visit wwwfoamixpharmacom   contact us investor relations dorit hayon michael rice foamix pharmaceuticals ltd lifesci advisors llc   irfoamixpharmacom   mricelifesciadvisorscom   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesfoamixpharmaceuticalstopresentatthejefferiesglobalhealthcareconferencehtml source foamix pharmaceuticals ltd the information on this page is provided by pr newswire all rights reserved reproduction or redistribution of this content without prior written consent from pr newswire is strictly prohibited is not responsible for this content learn more about this service about pr newswire the information on this page is provided by pr newswire the business journals is not responsible for this content learn more foamix pharmaceuticals ltd  product pipeline review    market research reports® inc skip to main content home faqs contact us become publisher blog  items  search form search this site search you are here home catalog pharma  healthcare company reports pharma  healthcare foamix pharmaceuticals ltd  product pipeline review   foamix pharmaceuticals ltd  product pipeline review   printer versionsend by email publication id gmd publication date  september   pages   publisher global markets direct countries  global  publication license type  single user license pdf  site license pdf  global license pdf  please choose the suitable license type from above more details are at given under tab report license types below add to cart why to buy from us globally trusted brand we help executives from fortune  firms to startups with their market research needs thus we can help you too  shop with confidence if you have any presales questions related to this report pelase let us know using the report enquiry form below this will help us provide you with answers so that you can purchase with confidence secure checkout you can shop confidently as your online payments are processed using pci dss compliant secure payment gateways on our website frequently asked questions if you wish to read about frequently asked questions by our customers please visit our faqs page tabsdescription foamix pharmaceuticals ltd  product pipeline review   summary global markets direct’s ‘foamix pharmaceuticals ltd  product pipeline review  ’ provides an overview of the foamix pharmaceuticals ltd’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by foamix pharmaceuticals ltd complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of foamix pharmaceuticals ltd  the report provides overview of foamix pharmaceuticals ltd including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses foamix pharmaceuticals ltd’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features foamix pharmaceuticals ltd’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate foamix pharmaceuticals ltd’s strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for foamix pharmaceuticals ltd  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding foamix pharmaceuticals ltd’s pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents table of contents table of contents  list of tables  list of figures  foamix pharmaceuticals ltd snapshot  foamix pharmaceuticals ltd overview  key facts  foamix pharmaceuticals ltd  research and development overview  key therapeutic areas  foamix pharmaceuticals ltd  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  combination treatment modalities  pipeline products  partnered products  partnered productscombination treatment modalities  foamix pharmaceuticals ltd  pipeline products glance  foamix pharmaceuticals ltd  late stage pipeline products  phase iii productscombination treatment modalities  foamix pharmaceuticals ltd  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  foamix pharmaceuticals ltd  early stage pipeline products  preclinical productscombination treatment modalities  foamix pharmaceuticals ltd  drug profiles  urea  lactic acid  drug profile  product description  mechanism of action  rd progress  acyclovir  drug profile  product description  mechanism of action  rd progress  benzoyl peroxide  drug profile  product description  mechanism of action  rd progress  betamethasone valerate  drug profile  product description  mechanism of action  rd progress  ciclopirox olamine  drug profile  product description  mechanism of action  rd progress  doxycycline  drug profile  product description  mechanism of action  rd progress  estradiol hemihydrate  drug profile  product description  mechanism of action  rd progress  fmx  drug profile  product description  mechanism of action  rd progress  fmx  drug profile  product description  mechanism of action  rd progress  fmx  drug profile  product description  mechanism of action  rd progress  imiquimod  drug profile  product description  mechanism of action  rd progress  mometasone furoate  drug profile  product description  mechanism of action  rd progress  urea  drug profile  product description  mechanism of action  rd progress  foamix pharmaceuticals ltd  pipeline analysis  foamix pharmaceuticals ltd  pipeline products by target  foamix pharmaceuticals ltd  pipeline products by route of administration  foamix pharmaceuticals ltd  pipeline products by molecule type  foamix pharmaceuticals ltd  pipeline products by mechanism of action  foamix pharmaceuticals ltd  dormant projects  foamix pharmaceuticals ltd  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables foamix pharmaceuticals ltd key facts  foamix pharmaceuticals ltd  pipeline by indication   foamix pharmaceuticals ltd  pipeline by stage of development   foamix pharmaceuticals ltd  monotherapy products in pipeline   foamix pharmaceuticals ltd  combination treatment modalities in pipeline   foamix pharmaceuticals ltd  partnered products in pipeline   foamix pharmaceuticals ltd  partnered products combination treatment modalities   foamix pharmaceuticals ltd  phase iii   foamix pharmaceuticals ltd  phase ii   foamix pharmaceuticals ltd  phase i   foamix pharmaceuticals ltd  preclinical   foamix pharmaceuticals ltd  pipeline by target   foamix pharmaceuticals ltd  pipeline by route of administration   foamix pharmaceuticals ltd  pipeline by molecule type   foamix pharmaceuticals ltd  pipeline products by mechanism of action   foamix pharmaceuticals ltd  dormant developmental projects  foamix pharmaceuticals ltd subsidiaries  list of figures foamix pharmaceuticals ltd  pipeline by top  indication   foamix pharmaceuticals ltd  pipeline by stage of development   foamix pharmaceuticals ltd  monotherapy products in pipeline   foamix pharmaceuticals ltd  pipeline by target   foamix pharmaceuticals ltd  pipeline by route of administration   foamix pharmaceuticals ltd  pipeline by molecule type   foamix pharmaceuticals ltd  pipeline products by mechanism of action   report license types single user license pdf this license allows for use of a publication by one person this person may print out a single copy of the publication this person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher this person cannot share the publication or any information contained therein with any other person or persons unless a global license is purchased a single user license must be purchased for every person that wishes to use the publication within the same organization customers who infringe these license terms are liable for a global license fee   site license pdf this license allows for use of a publication by all users within one corporate location eg a regional office these users may print out a single copy of the publication these users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher these users cannot share the publication or any information contained therein with any other person or persons outside the corporate location for which the publication is purchased unless a global license is purchased a site user license must be purchased for every corporate location by an organization that wishes to use the publication within the same organization customers who infringe these license terms are liable for a global license fee   global license pdf this license allows for use of a publication by unlimited users within the purchasing organization eg all employees of a single company each of these people may use the publication on any computer and may print out the report but may not share the publication or any information contained therein with any other person or persons outside of the organization these employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher if applicable report enquiry do you have more questions related to this market research report after going through the description and table of contents we are here to help please use the form given below to let us know your questions related to this report kindly use your official email address and contact number to ensure speedy response first name  last name  company  email address  phone including international code  report title  your inquiry  captchathis question is for testing whether you are a human visitor and to prevent automated spam submissions math question      solve this simple math problem and enter the result eg for  enter  submit company reports pharma  healthcarepharma  healthcare please note that the report cover image shown above is for representation purpose only actual report cover may vary  single user license pdf market research reports® inc httpwwwmarketresearchreportscom related market research reports publication price hoya corporation   medical equipment  deals and alliances profile summary  cook medical inc  medical equipment  deals and alliances profile summary  ossur hf ossr  medical equipment  deals and alliances profile summary  atricure inc atrc  medical equipment  deals and alliances profile summary  resmed inc rmd  medical equipment  deals and alliances profile summary  zimmer biomet holdings inc zbh  medical equipment  deals and alliances profile summary  reva medical inc rva  medical equipment  deals and alliances profile summary  stereotaxis inc stxs  medical equipment  deals and alliances profile summary  brainlab ag  medical equipment  deals and alliances profile summary  histogenics corp hsgx  medical equipment  deals and alliances profile summary  corium international inc cori  medical equipment  deals and alliances profile summary  johnson  johnson jnj  medical equipment  deals and alliances profile summary  clients who trust us need tailor made market research solution we can help you with that too contact us about us at market research reports inc we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best ie take timecritical decisions we work with our associate global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs be it custom research or syndicated research reports contact us market research reports inc  coastal hwy lewes de  usa usa  india  marketresearchreports email protected user login username  password  create new account request new password log in latest blog posts investment opportunities in taiwan semiconductor chemical and consumer goods will lead the pack global investment opportunities in ports and terminals stay connected sign up to our newsletter email address  subscribe research industries home automotive banking  finance business  government chemicals computing  electronics consumer  retail energy  utilities food  beverages industry  manufacturing marketing  advertising media pharma  healthcare telecom transport travel  leisure our company about us publications by country faqs privacy policy terms  conditions  copyright  market research reports inc all rights reserved m market research reports and the m market research reports logo are registered trademarks of market research reports inc disclaimer market research reports inc has no affiliation to and is not associated with any other websites or organizations we offer syndicated research reports like country analysis swot analysis competitive intelligence industry reports company reports and market analysis  trends reports and custom market research from our website marketresearchreportscom only if you are looking for a market research solution for your research requirements please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us